Pfizer Inc (PFE)

Biotech M&A has hit a record pace in 2026, with deal value reaching $216 billion so far this year, up from $118 billion over the same stretch last year, according to LSEG data.

The word “worst” here is not about business quality.

In this article, we will look at the stocks Jim Cramer shared his opinions on during Mad Money.

Dividend stocks can be tax-efficient, but only in a qualified sense.

Expect strong market gains heading into the second half of the year. It is a sentiment echoed by research firms on Wall Street in the aftermath of the de-escalation of tensions in the Middle East.

Is PFE a good stock to buy? We came across a bullish thesis on Pfizer Inc. on r/ValueInvesting by Dismal-Cancel4958. In this article, we will summarize the bulls’ thesis on PFE.

On June 9, Reuters reported that Philips' Future Health Index survey concluded that artificial intelligence improved clinical accuracy and increased patient capacity.

Dividend stocks remain a popular choice for income-focused investors. Financial experts often point to the broader market as a strong hunting ground for long-term dividend opportunities.

On  May 27, Reuters reported that Biohub, a philanthropic venture formed by Meta CEO Mark Zuckerberg and Dr. Priscilla Chan, developed a global model of protein biology to speed up drug discovery.